Molecular genetics of a cohort of 635 cases of phenylketonuria in a consanguineous population

Tina Shirzadeh, Amir Hossein Saeidian, Hamideh Bagherian, Shadab Salehpour, Aria Setoodeh, Mohammad Reza Alaei, Leila Youssefian, Ashraf Samavat, Andrew Touati, Mohammad‐Sadegh Fallah, Hassan Vahidnezhad, Morteza Karimipoor, Sarah Azadmehr, Marzieh Raeisi, Ameneh Bandehi Sarhadi, Fatemeh Zafarghandi Motlagh, Mojdeh Jamali, Zahra Zeinali, Maryam Abiri, Sirous Zeinali, Additional individual contributors

Phenylketonuria (PKU) is an inborn error of amino acid metabolism caused by mutations in the phenylalanine hydroxylase (PAH) gene, characterized by intellectual deficit and neuropsychiatric complications in untreated patients with estimated frequency of about one in 10,000 to 15,000 live births. PAH deficiency can be detected by neonatal screening in nearly all cases with hyperphenylalaninemia on a heel prick blood spot. Molecular testing of the PAH gene can then be performed in affected family members. Herein, we report molecular study of 635 patients genetically diagnosed with PKU from all ethnicities in Iran. The disease-causing mutations were found in 611 (96.22%) of cases. To the best of our knowledge, this is the most comprehensive molecular genetics study of PKU in Iran, identifying 100 distinct mutations in the PAH gene, including 15 previously unreported mutations. Interestingly, we found unique cases of PKU with uniparental disomy, germline mosaicism, and coinheritance with another Mendelian single-gene disorder that provides new insights for improving the genetic counseling, prenatal diagnosis (PND), and/or pre-implantation genetic diagnosis (PGD) for the inborn error of metabolism group of disorders.